as of 12-17-2025 3:34pm EST
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
| Founded: | 1990 | Country: | United States |
| Employees: | N/A | City: | HOUSTON |
| Market Cap: | 1.2B | IPO Year: | 1992 |
| Target Price: | $108.20 | AVG Volume (30 days): | 199.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 2.38 | EPS Growth: | 153.49 |
| 52 Week Low/High: | $62.77 - $98.07 | Next Earning Date: | 11-05-2025 |
| Revenue: | $750,948,000 | Revenue Growth: | 17.51% |
| Revenue Growth (this year): | 19.53% | Revenue Growth (next year): | 6.33% |
COO
Avg Cost/Share
$71.01
Shares
743
Total Value
$52,760.43
Owned After
20,740
SEC Form 4
Director
Avg Cost/Share
$69.00
Shares
4,000
Total Value
$276,000.00
Owned After
24,786
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| REEVE GRAHAM D. | USPH | COO | Nov 24, 2025 | Sell | $71.01 | 743 | $52,760.43 | 20,740 | |
| Gilmartin Kathleen A | USPH | Director | Nov 20, 2025 | Buy | $69.00 | 4,000 | $276,000.00 | 24,786 |
See how USPH stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "USPH U.S. Physical Therapy Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.